NO20005131L - Nye behandlinger for nervøse forstyrrelser - Google Patents
Nye behandlinger for nervøse forstyrrelserInfo
- Publication number
- NO20005131L NO20005131L NO20005131A NO20005131A NO20005131L NO 20005131 L NO20005131 L NO 20005131L NO 20005131 A NO20005131 A NO 20005131A NO 20005131 A NO20005131 A NO 20005131A NO 20005131 L NO20005131 L NO 20005131L
- Authority
- NO
- Norway
- Prior art keywords
- new treatments
- nervous disorders
- reboxetine
- ocd
- obsessive
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 2
- 208000019906 panic disease Diseases 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 abstract 1
- 229960003770 reboxetine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Mobile Radio Communication Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8163298P | 1998-04-13 | 1998-04-13 | |
| IT98MI000870 IT1305322B1 (it) | 1998-04-23 | 1998-04-23 | Uso di reboxetina per il trattamento di disturbi nervosi |
| US8503398P | 1998-05-11 | 1998-05-11 | |
| PCT/US1999/004288 WO1999052518A2 (en) | 1998-04-13 | 1999-04-02 | New treatments for nervous disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005131D0 NO20005131D0 (no) | 2000-10-12 |
| NO20005131L true NO20005131L (no) | 2000-10-12 |
Family
ID=11379879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005131A NO20005131L (no) | 1998-04-13 | 2000-10-12 | Nye behandlinger for nervøse forstyrrelser |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6391876B1 (ko) |
| EP (1) | EP1071418B1 (ko) |
| JP (1) | JP2002511408A (ko) |
| KR (1) | KR100555279B1 (ko) |
| CN (1) | CN1197569C (ko) |
| AT (1) | ATE277617T1 (ko) |
| AU (1) | AU755612B2 (ko) |
| BR (1) | BR9909476A (ko) |
| CA (1) | CA2320722A1 (ko) |
| DE (1) | DE69920679T2 (ko) |
| DK (1) | DK1071418T3 (ko) |
| EA (1) | EA003546B1 (ko) |
| ES (1) | ES2228035T3 (ko) |
| HU (1) | HUP0101748A3 (ko) |
| IL (1) | IL138887A0 (ko) |
| IT (1) | IT1305322B1 (ko) |
| NO (1) | NO20005131L (ko) |
| NZ (1) | NZ507693A (ko) |
| PL (1) | PL194039B1 (ko) |
| PT (1) | PT1071418E (ko) |
| SI (1) | SI1071418T1 (ko) |
| SK (1) | SK14482000A3 (ko) |
| TR (1) | TR200002970T2 (ko) |
| WO (1) | WO1999052518A2 (ko) |
| ZA (1) | ZA200004480B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500827B2 (en) * | 1998-05-08 | 2002-12-31 | Pharmacia & Upjohn Company | Drug combinations |
| DK1500395T3 (da) * | 1999-07-01 | 2006-06-19 | Pharmacia & Upjohn Co Llc | Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser |
| PL196996B1 (pl) | 1999-07-01 | 2008-02-29 | Upjohn Co | Zastosowanie optycznie czystej (S,S)-reboksetyny lub jej dopuszczalnej farmaceutycznie soli do wytwarzania leku |
| BR0115301A (pt) * | 2000-11-15 | 2004-12-14 | Lilly Co Eli | Uso de um inibidor seletivo da recaptação de norepinefrina |
| NZ537023A (en) * | 2002-06-17 | 2006-09-29 | Pharmacia Italia Spa | Pharmaceutical salts of reboxetine |
| US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| GB8419683D0 (en) | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
| GB2167407B (en) | 1984-11-22 | 1988-05-11 | Erba Farmitalia | Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof |
| US6066643A (en) * | 1997-10-17 | 2000-05-23 | Eli Lilly And Company | Potentiation of pharmaceuticals |
-
1998
- 1998-04-23 IT IT98MI000870 patent/IT1305322B1/it active
-
1999
- 1999-04-02 SK SK1448-2000A patent/SK14482000A3/sk unknown
- 1999-04-02 HU HU0101748A patent/HUP0101748A3/hu active IP Right Revival
- 1999-04-02 SI SI9930684T patent/SI1071418T1/xx unknown
- 1999-04-02 AU AU36351/99A patent/AU755612B2/en not_active Ceased
- 1999-04-02 NZ NZ507693A patent/NZ507693A/en unknown
- 1999-04-02 ES ES99918423T patent/ES2228035T3/es not_active Expired - Lifetime
- 1999-04-02 EA EA200001058A patent/EA003546B1/ru not_active IP Right Cessation
- 1999-04-02 CA CA002320722A patent/CA2320722A1/en not_active Abandoned
- 1999-04-02 DE DE69920679T patent/DE69920679T2/de not_active Expired - Fee Related
- 1999-04-02 WO PCT/US1999/004288 patent/WO1999052518A2/en active IP Right Grant
- 1999-04-02 US US09/673,768 patent/US6391876B1/en not_active Expired - Fee Related
- 1999-04-02 EP EP99918423A patent/EP1071418B1/en not_active Expired - Lifetime
- 1999-04-02 IL IL13888799A patent/IL138887A0/xx not_active IP Right Cessation
- 1999-04-02 CN CNB99804010XA patent/CN1197569C/zh not_active Expired - Fee Related
- 1999-04-02 AT AT99918423T patent/ATE277617T1/de not_active IP Right Cessation
- 1999-04-02 JP JP2000543128A patent/JP2002511408A/ja active Pending
- 1999-04-02 PT PT99918423T patent/PT1071418E/pt unknown
- 1999-04-02 DK DK99918423T patent/DK1071418T3/da active
- 1999-04-02 KR KR1020007011336A patent/KR100555279B1/ko not_active IP Right Cessation
- 1999-04-02 BR BR9909476-2A patent/BR9909476A/pt not_active Application Discontinuation
- 1999-04-02 TR TR2000/02970T patent/TR200002970T2/xx unknown
- 1999-04-02 PL PL99346294A patent/PL194039B1/pl unknown
-
2000
- 2000-08-29 ZA ZA200004480A patent/ZA200004480B/en unknown
- 2000-10-12 NO NO20005131A patent/NO20005131L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2375908A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
| HK1104968A1 (en) | Use of immunomodulatory compounds in the manufacture of a medicament for the treatment and management of cancers and other diseases, and compositions thereof | |
| WO2000064441A3 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
| CA2503810A1 (en) | Therapeutic agent for fibromyalgia | |
| EE200200107A (et) | Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
| WO2004105690A3 (en) | Treatment of chronic pain associated with drug or radiation therapy | |
| NO20005131L (no) | Nye behandlinger for nervøse forstyrrelser | |
| NO20005059L (no) | Nye behandlinger for nervøse lidelser | |
| WO2000076500A8 (en) | Compound for use as a medicament for treatment of disorders involving bronchocontraction | |
| MXPA04001805A (es) | Nueva forma de dosificacion oral de liberacion prolongada. | |
| EP1632235A3 (en) | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders | |
| NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
| BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
| WO2002043566A3 (en) | Devices and methods for treating low blood sugar levels | |
| TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
| NZ511226A (en) | Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder | |
| SE0102888D0 (sv) | New formulation | |
| MXPA04001812A (es) | Nueva forma de dosificacion oral de liberacion prolongada. | |
| RU2000106699A (ru) | Способ лечения заболеваний методом настройки биоритмов организма |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |